{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:22:25Z","timestamp":1789647745890,"version":"4.0.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>Sudden cardiac death is the most unpredictable and devastating consequence of hypertrophic cardiomyopathy, most often caused by persistent ventricular tachycardia or ventricular fibrillation. Although myocardial hypertrophy, fibrosis, and microvascular disorders are the main mechanisms of persistent reentrant ventricular arrhythmias in patients with advanced hypertrophic cardiomyopathy, the cardiomyocyte mechanism based on ion channel abnormalities may play an important role in the early stages of the disease.<\/jats:p>","DOI":"10.1097\/crd.0000000000000612","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T09:26:00Z","timestamp":1696843560000},"page":"260-264","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Mechanism of Ion Channel Impairment in the Occurrence of Arrhythmia in Patients with Hypertrophic Cardiomyopathy"],"prefix":"10.1097","volume":"33","author":[{"given":"Ke","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery"},{"name":"The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery"},{"name":"The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery"},{"name":"The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery"},{"name":"The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"R1-20250404","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy.","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"R2-20250404","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250404","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","article-title":"Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"R4-20250404","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0195-668X(03)00479-2","article-title":"American College of Cardiology\/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. a report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology Committee for practice guidelines.","volume":"24","author":"Maron","year":"2003","journal-title":"Eur Heart J"},{"key":"R5-20250404","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjmed.2003.10.012","article-title":"Hypertrophic cardiomyopathy: an important global disease.","volume":"116","author":"Maron","year":"2004","journal-title":"Am J Med"},{"key":"R6-20250404","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"R7-20250404","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.115.020254","article-title":"Sudden cardiac death in the young.","volume":"133","author":"Ackerman","year":"2016","journal-title":"Circulation"},{"key":"R8-20250404","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"R9-20250404","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction.","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"key":"R10-20250404","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12265-009-9137-2","article-title":"The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.","volume":"2","author":"Olivotto","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"R11-20250404","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"R12-20250404","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"R13-20250404","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R14-20250404","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"R15-20250404","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamacardio.2018.0789","article-title":"Long-term outcomes of pediatric-onset hypertrophic cardiomyopathy and age-specific risk factors for lethal arrhythmic events.","volume":"3","author":"Maurizi","year":"2018","journal-title":"JAMA Cardiol"},{"key":"R16-20250404","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"R17-20250404","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu205","article-title":"Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.","volume":"104","author":"Han","year":"2014","journal-title":"Cardiovasc Res"},{"key":"R18-20250404","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/bph.14223","article-title":"Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium.","volume":"175","author":"Ferrantini","year":"2018","journal-title":"Br J Pharmacol"},{"key":"R19-20250404","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacbts.2019.06.004","article-title":"Electrophysiological and contractile effects of disopyramide in patients with obstructive hypertrophic cardiomyopathy: a translational study.","volume":"4","author":"Coppini","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"R20-20250404","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2021.04.009","article-title":"Translational investigation of electrophysiology in hypertrophic cardiomyopathy.","volume":"157","author":"Flenner","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"R21-20250404","doi-asserted-by":"crossref","first-page":"H620","DOI":"10.1152\/ajpheart.00167.2017","article-title":"Remodeling of repolarization and arrhythmia susceptibility in a myosin-binding protein C knockout mouse model.","volume":"313","author":"Toib","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R22-20250404","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehr021","article-title":"Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy.","volume":"32","author":"Johnson","year":"2011","journal-title":"Eur Heart J"},{"key":"R23-20250404","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0008-6363(02)00735-6","article-title":"Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis.","volume":"57","author":"Pogwizd","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R24-20250404","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0008-6363(02)00841-6","article-title":"[Na+]i handling in the failing human heart.","volume":"57","author":"Pieske","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R25-20250404","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.yjmcc.2007.03.906","article-title":"Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics.","volume":"42","author":"Haim","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"R26-20250404","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.0000059562.91384.1A","article-title":"Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.","volume":"92","author":"Knollmann","year":"2003","journal-title":"Circ Res"},{"key":"R27-20250404","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.yjmcc.2012.03.009","article-title":"Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.","volume":"52","author":"Fraysse","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"R28-20250404","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCRESAHA.119.315715","article-title":"Interaction of the joining region in junctophilin-2 With the L-Type Ca(2+) channel is pivotal for cardiac dyad assembly and intracellular Ca(2+) dynamics.","volume":"128","author":"Gross","year":"2021","journal-title":"Circ Res"},{"key":"R29-20250404","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCRESAHA.107.156380","article-title":"Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.","volume":"101","author":"Robinson","year":"2007","journal-title":"Circ Res"},{"key":"R30-20250404","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1152\/physrev.00018.2010","article-title":"CaMKII in the cardiovascular system: sensing redox states.","volume":"91","author":"Erickson","year":"2011","journal-title":"Physiol Rev"},{"key":"R31-20250404","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1073\/pnas.0809148106","article-title":"Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias.","volume":"106","author":"Sato","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-20250404","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijcard.2012.09.034","article-title":"The onset mechanisms of ventricular tachycardia.","volume":"167","author":"Ulus","year":"2013","journal-title":"Int J Cardiol"},{"key":"R33-20250404","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cvr\/cvv019","article-title":"Research priorities in sarcomeric cardiomyopathies.","volume":"105","author":"van der Velden","year":"2015","journal-title":"Cardiovasc Res"},{"key":"R34-20250404","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/01.CIR.0000164234.24957.75","article-title":"Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy.","volume":"111","author":"Sanbe","year":"2005","journal-title":"Circulation"},{"key":"R35-20250404","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1038\/s41598-018-22936-z","article-title":"Successful knock-in of hypertrophic cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs.","volume":"8","author":"Montag","year":"2018","journal-title":"Sci Rep"},{"key":"R36-20250404","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"R37-20250404","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy.","volume":"141","author":"Toepfer","year":"2020","journal-title":"Circulation"},{"key":"R38-20250404","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1253\/circj.CJ-14-0182","article-title":"Modeling inherited cardiac disorders.","volume":"78","author":"Sallam","year":"2014","journal-title":"Circ J"},{"key":"R39-20250404","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells.","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"R40-20250404","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13287-022-02905-0","article-title":"Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"R41-20250404","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hrthm.2017.09.024","article-title":"CRISPR correction of the PRKAG2 gene mutation in the patient\u2019s induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.","volume":"15","author":"Ben Jehuda","year":"2018","journal-title":"Heart Rhythm"},{"key":"R42-20250404","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"key":"R43-20250404","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jacc.2010.07.045","article-title":"Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine.","volume":"57","author":"Morita","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R44-20250404","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac late sodium channel current is a molecular target for the Sodium\/Glucose cotransporter 2 inhibitor empagliflozin.","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"key":"R45-20250404","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.hrthm.2013.03.023","article-title":"Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967.","volume":"10","author":"Sicouri","year":"2013","journal-title":"Heart Rhythm"},{"key":"R46-20250404","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1111\/jcmm.15431","article-title":"Up-regulation of miR-195 contributes to cardiac hypertrophy-induced arrhythmia by targeting calcium and potassium channels.","volume":"24","author":"Xuan","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R47-20250404","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCEP.108.842799","article-title":"Ca\/calmodulin kinase II differentially modulates potassium currents.","volume":"2","author":"Wagner","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R48-20250404","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.RES.64.5.977","article-title":"Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.","volume":"64","author":"January","year":"1989","journal-title":"Circ Res"},{"key":"R49-20250404","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/chan.4.1.10531","article-title":"Elevated InsP3R expression underlies enhanced calcium fluxes and spontaneous extra-systolic calcium release events in hypertrophic cardiac myocytes.","volume":"4","author":"Harzheim","year":"2010","journal-title":"Channels (Austin)"},{"key":"R50-20250404","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/hc3101.093869","article-title":"Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy.","volume":"104","author":"Somura","year":"2001","journal-title":"Circulation"},{"key":"R51-20250404","doi-asserted-by":"crossref","first-page":"e126544","DOI":"10.1172\/jci.insight.126544","article-title":"Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2.","volume":"5","author":"Alvarado","year":"2019","journal-title":"JCI Insight"},{"key":"R52-20250404","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2015.12.013","article-title":"Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.","volume":"91","author":"Crocini","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"R53-20250404","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1074\/jbc.RA118.002081","article-title":"Hypertrophic cardiomyopathy mutations increase myofilament Ca(2+) buffering, alter intracellular Ca(2+) handling, and stimulate Ca(2+)-dependent signaling.","volume":"293","author":"Robinson","year":"2018","journal-title":"J Biol Chem"},{"key":"R54-20250404","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.3390\/cells10102789","article-title":"Ion channel impairment and myofilament Ca(2+) sensitization: two parallel mechanisms underlying arrhythmogenesis in hypertrophic cardiomyopathy.","volume":"10","author":"Santini","year":"2021","journal-title":"Cells"},{"key":"R55-20250404","doi-asserted-by":"crossref","first-page":"e16423","DOI":"10.15252\/emmm.202216423","article-title":"Disease modeling of a mutation in \u03b1-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.","volume":"14","author":"Prondzynski","year":"2022","journal-title":"EMBO Mol Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:59:55Z","timestamp":1786035595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000612","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}